Navigation Links
First U.S. Patients Enrolled in the REALISM Continued Access Study
Date:2/2/2009

ay, 6-month and 12-month clinical follow-up. REALISM will collect new information regarding functional capacity following treatment with the MitraClip(R) device.

"The REALISM study will allow patients suffering from the effects of MR to continue to have access to the MitraClip(R) therapy under a controlled protocol while data from the EVEREST II trial are being finalized," said Ted Feldman, M.D., director of the cardiac catheterization lab at Evanston Hospital and co-principal investigator of the EVEREST trial. "This will also allow us to observe the use of the MitraClip(R) system under real world conditions and will allow us to further study changes in functional capacity after successful treatment with the MitraClip(R) system."

"Initiating enrollment in REALISM is an important milestone for Evalve," said Ferolyn Powell, president and chief executive officer of Evalve. "REALISM allows participating EVEREST investigators continued access to the MitraClip(R) therapy for patients suffering from MR. As we make progress toward filing the MitraClip(R) system premarket approval application with the FDA, this study also allows physicians to gain additional experience with the system and enables patients to potentially benefit from a less invasive treatment option."

The MitraClip(R) system is the only commercially available treatment option for non-surgical mitral valve repair in Europe.

About the MitraClip(R) Procedure

Percutaneous mitral repair with Evalve's MitraClip(R) system is performed by physicians in the catheterization laboratory. The heart beats normally during the procedure, and therefore does not require a heart-lung bypass machine. In addition to improving blood flow through the heart, the procedure may also relieve symptoms such as fatigue and shortness of breath that often affect patients with significant MR. After treatment, patients generally recover quickly. The
'/>"/>

SOURCE Evalve, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
3. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
4. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
5. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
6. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
7. Tainted Chinese Food Ingredients First Discovered in 2005
8. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
11. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... , July 14, 2014  Invivotek L.L.C., ... is pleased to announce that its animal research ... for the Assessment and Accreditation of Laboratory Animal ... of animals in science worldwide through voluntary accreditation ... for animal care and use in 38 countries. ...
(Date:7/14/2014)... , July 14, 2014  Today, ATS Labs, ... that it acquired the assets of MicroTest Labs, Inc. ... acquisition of MTL is the first step in the ... laboratory services platform to support the medical device and ... as Accuratus Lab Services , a name that ...
(Date:7/14/2014)... July 14, 2014  Medac Pharma, Inc., a ... of new molecules and improving the effectiveness of ... Drug Administration (FDA) has approved Rasuvo™, a subcutaneous ... for rheumatoid arthritis (RA), polyarticular-course juvenile idiopathic arthritis ... 10 dosage strengths, ranging from 7.5 mg to ...
Breaking Medicine Technology:Invivotek Awarded Full AAALAC Accreditation for Excellence in Laboratory Animal Care and Use 2ATS Labs, Inc. Announces the Acquisition of MicroTest Labs, Inc. 2ATS Labs, Inc. Announces the Acquisition of MicroTest Labs, Inc. 3Medac Pharma, Inc. Secures FDA Approval of Rasuvo (methotrexate) injection for Rheumatoid Arthritis, Poly-Articular-Course Juvenile Idiopathic Arthritis and Psoriasis 2Medac Pharma, Inc. Secures FDA Approval of Rasuvo (methotrexate) injection for Rheumatoid Arthritis, Poly-Articular-Course Juvenile Idiopathic Arthritis and Psoriasis 3Medac Pharma, Inc. Secures FDA Approval of Rasuvo (methotrexate) injection for Rheumatoid Arthritis, Poly-Articular-Course Juvenile Idiopathic Arthritis and Psoriasis 4Medac Pharma, Inc. Secures FDA Approval of Rasuvo (methotrexate) injection for Rheumatoid Arthritis, Poly-Articular-Course Juvenile Idiopathic Arthritis and Psoriasis 5Medac Pharma, Inc. Secures FDA Approval of Rasuvo (methotrexate) injection for Rheumatoid Arthritis, Poly-Articular-Course Juvenile Idiopathic Arthritis and Psoriasis 6Medac Pharma, Inc. Secures FDA Approval of Rasuvo (methotrexate) injection for Rheumatoid Arthritis, Poly-Articular-Course Juvenile Idiopathic Arthritis and Psoriasis 7Medac Pharma, Inc. Secures FDA Approval of Rasuvo (methotrexate) injection for Rheumatoid Arthritis, Poly-Articular-Course Juvenile Idiopathic Arthritis and Psoriasis 8
(Date:7/14/2014)... (PRWEB) July 14, 2014 Jordan Valley ... of a new comprehensive cancer center set to open ... will be the only hospital west of I-15 in ... cancer services , Additionally, Jordan Valley Medical Center has ... and cancer treatment planning systems for radiation therapy, radiosurgery ...
(Date:7/14/2014)... 14, 2014 The report “Intelligent ... [Physical Security, Life Safety, Facility Management], IT Technologies ... & Analysis (2014 - 2019)” defines and segments ... in-depth analysis and forecasting of revenues. The report ... restraints and opportunities impacting it, along with the ...
(Date:7/14/2014)... 2014 BCC Research ( http://www.bccresearch.com ... BIOLOGY: GLOBAL MARKETS , the global synthetic biology ... billion in 2018, with a five-year compound annual ... for the fastest growing segment, with anticipated $9.7 ... products in the pharmaceutical/diagnostics, chemical, energy, and agricultural ...
(Date:7/14/2014)... 13, 2014 (HealthDay News) -- Eye tests could be ... Alzheimer,s disease, two new studies suggest. In one ... certain eye test found a significant association between levels ... and levels of the plaques in the brain. Beta-amyloid ... This type of eye test could be used ...
(Date:7/14/2014)... Amy Norton HealthDay Reporter ... adults who enjoy mentally stimulating games may have bigger brains ... The study looked at the connection between playing games ... for adults in their 50s and 60s. Researchers found ... day performed better on tests of memory and other mental ...
Breaking Medicine News(10 mins):Health News:Jordan Valley Medical Center Set to Break Ground with New $10 Million Cancer Center 2Health News:Intelligent Building Automation Technologies Market Worth $74.8 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Intelligent Building Automation Technologies Market Worth $74.8 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Intelligent Building Automation Technologies Market Worth $74.8 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Global Market for Synthetic Biology to Reach Nearly $11.9 Billion by 2018 — Enabled Products Account for the Fastest Growing Segment with 36.7% CAGR 2Health News:Global Market for Synthetic Biology to Reach Nearly $11.9 Billion by 2018 — Enabled Products Account for the Fastest Growing Segment with 36.7% CAGR 3Health News:Eye Tests Might Help ID Alzheimer's, Studies Suggest 2Health News:Can Games, Puzzles Keep Aging Minds Sharp? 2Health News:Can Games, Puzzles Keep Aging Minds Sharp? 3
... Two animal studies published in the journal Carcinogenesis show that ... physically active mice// that had a round the clock access ... other study found that exercise and a restricted diet had ... in the animals. ,The first study exposed mice ...
... new finding and revelation comes in the form of health ... the heart. ,The petition proposed as a model qualified health// ... (150 mL) of green tea as a source of catechins ... disease. FDA has determined that the evidence is supportive, but ...
... concern over the high maternal mortality rate in Madhya ... groups to help check the menace//. ,With 13,000 ... maternal mortality rate of the state is one of ... women's meet at the missionary-run Asha Niketan Welfare Centre ...
... which stated that doctors can give drugs to end the ... the upper house of British parliament//. The assisted dying bill ... stated that doctors can prescribe lethal drugs to patients who ... live. These drugs can be administered by the patients to ...
... have become so inadequate that students are becoming increasingly ... vital organs with each other. ,Senior doctors ... medical students are not being properly trained. ... properly trained in anatomy. According to them teaching hours ...
... percentages of undernourished children in the world, the situation ... report released Thursday//. ,"India's Integrated Child Development Services ... current malnutrition crisis," states the report "India's Undernourished Children: ... of underweight children in India is among the highest ...
Cached Medicine News:Health News:Green tea’s health claims questioned: FD 2Health News:Green tea’s health claims questioned: FD 3Health News:Malnutrition Crisis On Rise In India: World Bank 2
... The VersaPulse® PowerSuite™ holmium laser ... properties for precise, virtually bloodless procedures. ... fragmenting urinary and gall bladder stones ... ideal multipurpose surgical tool. Because its ...
... The VersaPulse® PowerSuite™ holmium laser combines ... for precise, virtually bloodless procedures. It ... urinary and gall bladder stones of ... multipurpose surgical tool. Because its laser ...
Turnstile casting stand for easy and safe casting. The compact system sets up quickly and stores conveniently, and the non-stick coating prevents fiberglass or plaster from adhering to surface....
... Cemex features a unique self-contained ... clinically proven in Europe for ... integrating bone cement powder and ... system, Cemex is designed to ...
Medicine Products: